Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Medical Records Department, Hospital
DnaB Helicases
Unique amalgamation of primary and secondary structural elements transform peptaibols into potent bioactive cell-penetrating peptides.
Home Infusion Therapy
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. J Thromb Haemost. 2021 11; 19(11):2772-2780.
View in:
PubMed
subject areas
Aftercare
Aged
Anticoagulants
Humans
Patient Discharge
Risk Factors
Rivaroxaban
Treatment Outcome
Venous Thromboembolism
authors with profiles
Gary E Raskob